These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 18046314)
41. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate. Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066 [TBL] [Abstract][Full Text] [Related]
42. Heparan sulfate of perlecan is involved in glomerular filtration. Morita H; Yoshimura A; Inui K; Ideura T; Watanabe H; Wang L; Soininen R; Tryggvason K J Am Soc Nephrol; 2005 Jun; 16(6):1703-10. PubMed ID: 15872080 [TBL] [Abstract][Full Text] [Related]
43. Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Chen S; Wassenhove-McCarthy DJ; Yamaguchi Y; Holzman LB; van Kuppevelt TH; Jenniskens GJ; Wijnhoven TJ; Woods AC; McCarthy KJ Kidney Int; 2008 Aug; 74(3):289-99. PubMed ID: 18480751 [TBL] [Abstract][Full Text] [Related]
44. Changes in glomerular heparan sulfate in puromycin aminonucleoside nephrosis. Groggel GC; Hovingh P; Border WA; Linker A Am J Pathol; 1987 Sep; 128(3):521-7. PubMed ID: 2443012 [TBL] [Abstract][Full Text] [Related]
45. Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Maxhimer JB; Somenek M; Rao G; Pesce CE; Baldwin D; Gattuso P; Schwartz MM; Lewis EJ; Prinz RA; Xu X Diabetes; 2005 Jul; 54(7):2172-8. PubMed ID: 15983219 [TBL] [Abstract][Full Text] [Related]
47. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Parthasarathy N; Spiro RG Diabetes; 1982 Aug; 31(8 Pt 1):738-41. PubMed ID: 6219021 [TBL] [Abstract][Full Text] [Related]
48. HGSNAT enzyme deficiency results in accumulation of heparan sulfate in podocytes and basement membranes. Nagel L; Oliveira R; Pshezhetsky AV; Morales CR Histol Histopathol; 2019 Dec; 34(12):1377-1385. PubMed ID: 31157913 [TBL] [Abstract][Full Text] [Related]
49. Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat. Adler S; Baker P; Pritzl P; Couser WG J Lab Clin Med; 1985 Jul; 106(1):1-11. PubMed ID: 3891891 [TBL] [Abstract][Full Text] [Related]
50. Urinary heparanase activity in patients with Type 1 and Type 2 diabetes. Rops AL; van den Hoven MJ; Veldman BA; Salemink S; Vervoort G; Elving LD; Aten J; Wetzels JF; van der Vlag J; Berden JH Nephrol Dial Transplant; 2012 Jul; 27(7):2853-61. PubMed ID: 22187315 [TBL] [Abstract][Full Text] [Related]
51. Analysis of glomerular anionic charge status in children with IgA nephropathy using confocal laser scanning microscopy. Sakagami Y; Nakajima M; Takagawa K; Ueda T; Akazawa H; Maruhashi Y; Shimoyama H; Kamitsuji H; Yoshioka A Nephron Clin Pract; 2004; 96(3):c96-104. PubMed ID: 15056992 [TBL] [Abstract][Full Text] [Related]
52. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Vernier RL; Steffes MW; Sisson-Ross S; Mauer SM Kidney Int; 1992 Apr; 41(4):1070-80. PubMed ID: 1513088 [TBL] [Abstract][Full Text] [Related]
53. Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease. Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA Nephrology (Carlton); 2005 Apr; 10(2):167-73. PubMed ID: 15877677 [TBL] [Abstract][Full Text] [Related]
54. Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats. Reddi AS; Ramamurthi R; Miller M; Dhuper S; Lasker N Biochem Med Metab Biol; 1991 Feb; 45(1):119-31. PubMed ID: 2015105 [TBL] [Abstract][Full Text] [Related]
55. Heparanases produce distinct populations of heparan sulfate glycosaminoglycans in Chinese hamster ovary cells. Bame KJ; Robson K J Biol Chem; 1997 Jan; 272(4):2245-51. PubMed ID: 8999930 [TBL] [Abstract][Full Text] [Related]
56. Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis. Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA J Am Soc Nephrol; 2004 Jan; 15(1):68-78. PubMed ID: 14694159 [TBL] [Abstract][Full Text] [Related]
57. The inhibitory action of oxygen radical scavengers on proteinuria and glomerular heparan sulphate loss in the isolated perfused kidney. Tay M; Comper WD; Vassiliou P; Glasgow EF; Baker MS; Pratt L Biochem Int; 1990; 20(4):767-78. PubMed ID: 2141255 [TBL] [Abstract][Full Text] [Related]
58. Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Patel VN; Knox SM; Likar KM; Lathrop CA; Hossain R; Eftekhari S; Whitelock JM; Elkin M; Vlodavsky I; Hoffman MP Development; 2007 Dec; 134(23):4177-86. PubMed ID: 17959718 [TBL] [Abstract][Full Text] [Related]
59. Urinary heparan sulfate proteoglycan excretion in black African women with pre-eclampsia. Khedun SM; Naicker T; Moodley J; Gathiram P Acta Obstet Gynecol Scand; 2002 Apr; 81(4):308-12. PubMed ID: 11952459 [TBL] [Abstract][Full Text] [Related]
60. Distribution of de novo synthesized sulfated glycosaminoglycans in the glomerular basement membrane and mesangial matrix. Kanwar YS; Rosenzweig LJ; Jakubowski ML Lab Invest; 1983 Aug; 49(2):216-25. PubMed ID: 6410121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]